icatibant and Acute-Kidney-Injury

icatibant has been researched along with Acute-Kidney-Injury* in 1 studies

Other Studies

1 other study(ies) available for icatibant and Acute-Kidney-Injury

ArticleYear
Role of tissue kallikrein in prevention and recovery of gentamicin-induced renal injury.
    Toxicological sciences : an official journal of the Society of Toxicology, 2008, Volume: 102, Issue:2

    Gentamicin is an aminoglycoside antibiotic that induces severe nephrotoxicity and acute renal failure. In the current project, we investigated the protective effects of tissue kallikrein (TK) protein administration (1 mug/h via osmotic minipumps) on kidney damage, apoptosis, and inflammation both during and after a 10-day regimen of gentamicin (80 mg/kg body weight/day sc) in Sprague-Dawley rats. TK infusion during gentamicin treatment significantly attenuated drug-induced renal dysfunction, cortical damage, and apoptosis. Moreover, TK reduced inflammatory cell accumulation in conjunction with diminished superoxide production and decreased expression of tumor necrosis factor-alpha, monocyte chemoattractant protein-1, and intercellular adhesion molecule-1. The protective effects of TK were blocked by coinfusion of icatibant (1.3 mug/h), indicating a kinin B2 receptor-mediated signaling event. After cessation of gentamicin treatment, TK infusion for 2 weeks completely restored kidney histology and morphology comparable to that of saline-treated animals. Furthermore, TK reduced gentamicin-induced renal dysfunction and fibrosis as evidenced by decreased myofibroblast and collagen accumulation in the kidney. In vitro, gentamicin increased the number of apoptotic cells and caspase-3 activity, but decreased phosphorylation of the prosurvival kinase Akt, in immortalized rat proximal tubular cells; addition of TK and bradykinin prevented these effects. In conclusion, our findings indicate that kallikrein/kinin prevents and promotes recovery of gentamicin-induced renal injury by inhibiting apoptosis, inflammatory cell recruitment, and fibrotic lesions through suppression of oxidative stress and proinflammatory mediator expression in animals during and after gentamicin treatment.

    Topics: Acute Kidney Injury; Animals; Anti-Bacterial Agents; Apoptosis; Blood Pressure; Blood Urea Nitrogen; Bradykinin; Cell Line, Transformed; Chemokine CCL2; Collagen; Disease Models, Animal; Drug Antagonism; Gentamicins; Injections, Subcutaneous; Intercellular Adhesion Molecule-1; Kidney; Male; Nephritis, Interstitial; Rats; Rats, Sprague-Dawley; Recovery of Function; Superoxides; Tissue Kallikreins; Tumor Necrosis Factor-alpha

2008